Generate the Evidence Needed to Support Chemical Development
Once a candidate enters full development, evidence generation can become expensive and time-consuming. The programme must address the remaining scientific uncertainties while anticipating the requirements of the intended regulatory pathway.
Blue Frog helps clients develop proportionate chemical testing strategies, select suitable methods and laboratories, oversee studies and interpret the resulting evidence.
We keep each activity connected to the substance, intended uses, agreed development targets and decisions that remain to be made.
Turning Regulatory Data Gaps into a Testing Strategy
A data gap does not automatically justify a study. Its significance depends on the proposed uses, regulatory context, existing evidence and whether the result could affect development.
We review the outstanding human health, environmental and physicochemical questions and determine how they should be addressed. This includes considering whether existing data, read-across, weight of evidence or new approach methodologies (NAMs) can contribute before more extensive testing is commissioned.
Where experimental work is needed, we help prioritise and sequence it into a pragmatic tiered testing strategy. Studies capable of identifying a fundamental barrier can be placed before more expensive or dependent work, allowing the programme to respond to evidence as it emerges.
Selecting Appropriate Chemical Safety Studies
The appropriate method depends on both the scientific question and the intended use of the data.
Blue Frog can help evaluate new approach methodologies (NAMs) and determine where established test guidelines may be required. We translate the evidence need into a clear study specification and help ensure that the proposed method, design and reporting will provide information suitable for its intended purpose.
This may include toxicological, ecotoxicological, environmental fate or physicochemical studies, selected according to the specific substance, material and regulatory context.
Laboratory Selection & Scientific Oversight
Selecting a laboratory which offers NAMs can be difficult, often due to absence of test guidelines, or laboratories with experience, or able to execute the studies. However, choosing a laboratory involves more than identifying one that offers the relevant test.
We can help review laboratory capabilities, proposals, methods, costs and timescales. Once work begins, we can provide scientific liaison, monitor progress and review protocols, results and draft reports.
This independent oversight helps identify issues while they can still be addressed and ensures that study findings are interpreted within the wider chemical safety and regulatory evidence base.
Reviewing the Innovation Against its Targets
New evidence may confirm the assumptions made during scoping and feasibility assessment—or challenge them.
We integrate study results with the existing evidence and reassess the human health, environmental, physicochemical and exposure conclusions. We also review the remaining data gaps, regulatory implications and progress against the agreed safety targets.
Where results identify a significant concern, we help determine whether the programme should continue, be refined or return to an earlier decision point.
Testing Strategy & Study Support Package
A typical evidence-development engagement may provide:
Laboratory identification.
A prioritised chemical testing and evidence strategy.
Tiered testing strategy and decision points.
Study specifications and laboratory briefs.
Scientific review of laboratory proposals.
Protocol, progress and draft-report reviews.
Integrated interpretation of study results.
Updated hazard, exposure and data-gap conclusions.
Revised regulatory cost and timescale projections.
A regulatory readiness or stage-gate evidence package.
Recommendations for progression or further refinement.
Informed Development Decision
Is the chemical, material or technology ready to progress towards product, process or regulatory development?
Blue Frog provides a clear account of what the evidence supports, where limitations remain and what additional work may be needed for the intended route to market.
Build a Proportionate Chemical Evidence Programme
We can support a complete programme or provide focused input on testing strategy, laboratory selection, study design, monitoring or interpretation.
